Frontlight ResearchEarly access
Liver and biliary tract cancer trials in Belgium
18 of 29 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
- Where
- Leuven
- Age
- 18 years and over
- People
- 134 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00 - No phaseNot yet taking people in BelgiumINPACT: Implementation of Nutritional Support and Physical Activity During Cancer Treatment
- Where
- Kortrijk
- Age
- 18 years and over
- People
- 103
- Run by
- General Hospital Groeninge
See details and how to joinNCT07929597 - Phase 3CompletedEfficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer
- Where
- Bonheiden, Edegem, Leuven
- Age
- 18 years and over
- People
- 286 worldwide
- Run by
- Jazz Pharmaceuticals
See details and how to joinNCT06282575 · EU 2023-508219-21-00 - Phase 1/2Taking peopleA Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
- Where
- Charleroi, Gent, Leuven, Liège, Sint-Lambrechts-Woluwe
- Age
- 18 years and over
- People
- 680 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00 - Phase 1Taking peopleA First-in-human Study to Learn About the Safety of BAY 3547926 and How Well it Works in Participants With Advanced Liver Cancer
- Where
- Edegem, Kortrijk, Leuven, Sint-Lambrechts-Woluwe
- Age
- 18 years and over
- People
- 148 worldwide
- Run by
- Bayer
See details and how to joinNCT06764316 · EU 2024-516615-25-00 - Phase 3Taking peoplePhase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
- Where
- Anderlecht, Edegem, Gent, Leuven, Liège, Roeselare
- Age
- 18 years to 99 years
- People
- 620 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06467357 · EU 2023-508057-19-00 - Phase 1Taking peopleStudy of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Where
- Kortrijk
- Age
- 18 years and over
- People
- 1,394 worldwide
- Run by
- Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00 - Phase 2Taking peopleF-18 PSMA-11 PET for Imaging and Staging of Hepatocellular carcinoma with Evaluation of Survival
- Where
- Gent
- Age
- 18 years and over
- People
- 32
- Run by
- Universitair Ziekenhuis Gent
See details and how to join2023-508709-26-00 - Phase 3Taking peopleA Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
- Where
- Anderlecht, Edegem, Leuven, Liège, Roeselare
- Age
- 18 years and over
- People
- 1,100 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07221253 · EU 2025-523085-24-00 - Phase 3Taking peopleA Phase III, Randomized, Controlled, Global Multicenter Study to Evaluate the Efficacy and Safety of Oral Tinengotinib versus Physician’s Choice in Subjects with Fibroblast Growth Factor Receptor (FGFR) altered, Chemotherapy- and FGFR Inhibitor-Refractory/Relapsed Cholangiocarcinoma (FIRST-308)
- Where
- Edegem, Gent, Leuven
- Age
- 18 years and over
- People
- 126 worldwide
- Run by
- Transthera Sciences (Nanjing) Inc.
See details and how to join2023-505660-11-00 - Phase 1Taking peopleA Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
- Where
- Anderlecht
- Age
- 18 years and over
- People
- 714 worldwide
- Run by
- Seagen, a wholly owned subsidiary of Pfizer
See details and how to joinNCT05208762 · EU 2023-506604-18-00 - No phaseTaking peopleImproving the Use of Immunotherapy to Treat Liver Cancer
- Where
- Antwerp, Hasselt, Kortrijk, Roeselare
- Age
- 18 years and over
- People
- 300
- Run by
- Universitaire Ziekenhuizen KU Leuven
See details and how to joinNCT07623265 - Phase 3Not yet taking people in BelgiumPersonalized Medicine for Advanced Biliary Cancer Patients
- Where
- Brussels, Edegem, Leuven
- Age
- 18 years and over
- People
- 800 worldwide
- Run by
- UNICANCER
See details and how to joinNCT05615818 · EU 2022-502403-30-00 - Phase 4Taking peopleHOPE Against Cancer Recurrence in HCC
- Where
- Leuven, Woluwe-Saint-Lambert
- Age
- 18 years and over
- People
- 220 worldwide
- Run by
- Philipp Dutkowski
See details and how to joinNCT06717919 - No phaseNot yet taking people in BelgiumStereotactic Body Radiation Therapy After Chemotherapy for Unresectable Perihilar Cholangiocarcinoma
- Where
- Brussels, Wilrijk
- Age
- 18 years and over
- People
- 30 worldwide
- Run by
- Erasmus Medical Center
See details and how to joinNCT06493734 - Phase 3CompletedSystemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver
- Where
- Bruxelles
- Age
- 18 years and over
- People
- 348 worldwide
- Run by
- Federation Francophone de Cancerologie Digestive
See details and how to joinNCT02885753 · EU 2024-518553-41-00 - No phaseTaking peopleThe Dragon PLC Trial (DRAGON-PLC)
- Where
- Antwerp, Brussels, Ghent, Hasselt, Jette, Kortrijk, Liège, Yvoir
- Age
- 18 years and over
- People
- 358 worldwide
- Run by
- Maastricht University
See details and how to joinNCT06914648 - No phaseTaking peopleThe DRAGON 2 Trial
- Where
- Brussels, Ghent, Liège, Yvoir
- Age
- 18 years and over
- People
- 348 worldwide
- Run by
- Maastricht University
See details and how to joinNCT05428735